Skip to main content

ROCKWELL MEDICAL, INC.

corporate_fare Company Profile

ROCKWELL MEDICAL, INC.

RMTI·NASDAQ·Healthcare·CIK 0001041024

Rockwell Medical is a healthcare company that develops, manufactures, commercializes, and distributes hemodialysis products to dialysis providers globally. The company supplies liquid and dry, acid and bicarbonate concentrates for dialysis patients within the United States. Its registered trademarks include CitraPure®, Dri-Sate®, RenalPure®, and SteriLyte®.

ROCKWELL MEDICAL, INC. (NASDAQ:RMTI) is a publicly traded company in the Healthcare sector. Wiseek monitors RMTI SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Rockwell Medical Receives Nasdaq Delisting Notice for Minimum Bid Price Deficiency
  • Rockwell Medical Reports Significantly Improved Operating Cash Flow and 12-Month Liquidity Runway
  • Rockwell Medical Projects 2026 Profitability and Positive Cash Flow Amidst Operational Streamlining
  • Rockwell Medical Projects FY26 Revenue Between $70M and $75M
  • Rockwell Medical Finalizes Reverse Stock Split Proposal for Nasdaq Compliance, Retains High Dilution Potential

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$69.26M
Net Income
-$5.31M
Diluted EPS
-$0.15
Op. Cash Flow
-$659K
Free Cash Flow
-$1.2M
Gross Profit
$11.7M
Operating Income
-$4.69M
Cash & Equivalents
$10.71M
Total Debt
$8.83M
Debt / Equity
0.24×
Net Margin
-7.7%
Shares Outstanding
39.41M sh
Source: 10-K · filed 2026-03-26 · accession 0001628280-26-021186
$0.6248
52-week range · as of 2026-05-08 $0.737 – $2.1
Market cap
$24.66M
Volume
218.3K (0.7× avg)
3-mo avg 326.1K
Live data · 2026-06-14 06:50 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed RMTI - Latest Insights

RMTI
May 08, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
9
Rockwell Medical Receives Nasdaq Delisting Notice for Minimum Bid Price Deficiency
Price at Filing: $0.8338
Real-time Price: $0.6248 info
Change: -$0.209 (-25%) info
Market Cap: $24.661M info
Sentiment: Negative
View Wiseek Article
RMTI
May 07, 2026, 6:59 AM EDT
Filing Type: 10-Q
Importance Score:
8
Rockwell Medical Reports Significantly Improved Operating Cash Flow and 12-Month Liquidity Runway
Price at Filing: $0.830
Real-time Price: $0.6248 info
Change: -$0.2052 (-25%) info
Market Cap: $24.661M info
Sentiment: Positive
View Wiseek Article
RMTI
May 07, 2026, 6:16 AM EDT
Filing Type: 8-K
Importance Score:
8
Rockwell Medical Projects 2026 Profitability and Positive Cash Flow Amidst Operational Streamlining
Price at Filing: $0.807
Real-time Price: $0.6248 info
Change: -$0.1822 (-23%) info
Market Cap: $24.661M info
Sentiment: Positive
View Wiseek Article
RMTI
May 07, 2026, 6:01 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Rockwell Medical Projects FY26 Revenue Between $70M and $75M
Price at Filing: $0.807
Real-time Price: $0.6248 info
Change: -$0.1822 (-23%) info
Market Cap: $24.661M info
Sentiment: Neutral
View Wiseek Article
RMTI
Apr 30, 2026, 6:59 AM EDT
Filing Type: DEF 14A
Importance Score:
8
Rockwell Medical Finalizes Reverse Stock Split Proposal for Nasdaq Compliance, Retains High Dilution Potential
Price at Filing: $0.918
Real-time Price: $0.6248 info
Change: -$0.2932 (-32%) info
Market Cap: $24.661M info
Sentiment: Negative
View Wiseek Article
RMTI
Apr 20, 2026, 4:09 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Shareholders to Vote on Reverse Stock Split to Maintain Nasdaq Listing; Potential for Over 4000% Dilution Post-Split
Price at Filing: $0.9387
Real-time Price: $0.6248 info
Change: -$0.3139 (-33%) info
Market Cap: $24.661M info
Sentiment: Negative
View Wiseek Article
RMTI
Mar 26, 2026, 7:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Rockwell Medical Updates Investor Presentation with Long-Term Financial Framework and No Further Fundraising Needs
Price at Filing: $0.918
Real-time Price: $0.6248 info
Change: -$0.2932 (-32%) info
Market Cap: $24.661M info
Sentiment: Positive
View Wiseek Article
RMTI
Mar 26, 2026, 7:01 AM EDT
Filing Type: 10-K
Importance Score:
8
Rockwell Medical Reports Steep Revenue Decline, Operating Loss, and Negative Cash Flow in 2025 Annual Report
Price at Filing: $0.970
Real-time Price: $0.6248 info
Change: -$0.3452 (-36%) info
Market Cap: $24.661M info
Sentiment: Negative
View Wiseek Article
RMTI
Mar 26, 2026, 6:10 AM EDT
Filing Type: 8-K
Importance Score:
7
Rockwell Medical Reports Q4 & Full-Year 2025 Results: Achieves Adjusted EBITDA Profitability, Boosts Cash Position
Price at Filing: $0.797
Real-time Price: $0.6248 info
Change: -$0.1722 (-22%) info
Market Cap: $24.661M info
Sentiment: Positive
View Wiseek Article
RMTI
Jan 20, 2026, 6:32 AM EST
Filing Type: 8-K
Importance Score:
8
Rockwell Medical Reports Strong Preliminary Q4 & Full-Year 2025 Results with Positive Cash Flow and Improved Cash Position
Price at Filing: $1.08
Real-time Price: $0.6248 info
Change: -$0.4552 (-42%) info
Market Cap: $24.661M info
Sentiment: Positive
View Wiseek Article
RMTI
Jan 05, 2026, 6:33 AM EST
Filing Type: 8-K
Importance Score:
7
Rockwell Medical Extends DaVita Agreement with Favorable Product Price Increase
Price at Filing: $0.8875
Real-time Price: $0.6248 info
Change: -$0.2627 (-30%) info
Market Cap: $24.661M info
Sentiment: Positive
View Wiseek Article